Proteome Regulatory News (PRM)

5 Feb 2008 08:36

PROTEOME SCIENCES plc

("Proteome Sciences" or the "Company")

PRESS RELEASE

Statement re Share Price Movement

The Board of Proteome Sciences has noted the recent movement in the Company's share price and that they are not aware of any reason for the share price increase.

In the trading update released on 21 December 2007, the Board reported that it continued to view future prospects for TMT‚® commercialisation with increasing confidence, with the related licence negotiations expected to be concluded in early 2008. This remains the case and the Company will issue a further update on licence negotiations in due course.

Ends

For further information please visit www.proteomics.com.

Proteome Sciences plc Christopher Pearce James MalthouseChief Executive Officer Finance Director

christopher.pearce@proteomics.com james.malthouse@proteomics.com

Tel: +44 (0)1932 865065 Public Relations IKON Associates Coast CommunicationsAdrian Shaw Matt BaldwinTel: +44 (0)1483 535102 Tel: +44 (0)1233 503200Mobile: +44 (0)797 9900733 Mobile: +44 (0)7930 439739adrian@ikonassociates.com matt@coastcommunications.com Nominated Adviser

Landsbanki Securities (UK) Limited

Gareth Price / Thilo Hoffman Tel: +44 (0)20 7426 9000